Skip to search formSkip to main contentSkip to account menu

Raptiva

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2010
2010
BACKGROUND The use of biologic agents represents a remarkable advance for patients with psoriasis and psoriatic arthritis who… 
2009
2009
We discuss a patient with a history of a positive tuberculin skin test, who presented with severe, recalcitrant palmoplantar… 
2009
2009
Gastric Burkitt lymphoma (BL) is a rare highly aggressive non-Hodgkin lymphoma of mature B-cells accounting for only 5–7% of all… 
2008
2008
LDS751/SSC revealed: 4% lymphocytes, 2% monocytes, 66% granulocytes, 6% immature blast cells, 18% erythroblasts and other CD45… 
2008
2008
AbstractIntroduction: Hand and foot psoriasis may be more disabling than psoriasis at other body locations because of its… 
2006
2006
Recently, the biologics have emerged as a new class of drugs for systemic therapy of psoriasis with efalizumab (Raptiva) being…